Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Gut Microbes
|
March 21, 2024
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A Nevzorova
Alcoholism, Clinical and Experimental Research
|
July 20, 2018
The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease
Feifei Guo, Kang Zheng, Raquel Benedé-Ubieto, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
February 29, 2020
Guidelines and Considerations for Metabolic Tolerance Tests in Mice
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Pierluigi Ramadori, et al.
Journal of Clinical Medicine
|
April 3, 2021
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Vicente Flores-Perojo, et al.
Frontiers in Nutrition
|
May 3, 2024
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
Arantza Lamas-Paz, Mariana Mesquita, Marcos Garcia-Lacarte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 3, 2023
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
Pierluigi Ramadori, Marius Maximilian Woitok, Olga Estévez-Vázquez, et al.
Biomedicines
|
October 23, 2021
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, et al.
Cancers
|
January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Hepatology Communications
|
June 18, 2021
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Gut Microbes
|
February 21, 2026
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Rana Acar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Gut Microbes
|
March 21, 2024
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A Nevzorova
Alcoholism, Clinical and Experimental Research
|
July 20, 2018
The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease
Feifei Guo, Kang Zheng, Raquel Benedé-Ubieto, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
February 29, 2020
Guidelines and Considerations for Metabolic Tolerance Tests in Mice
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Pierluigi Ramadori, et al.
Journal of Clinical Medicine
|
April 3, 2021
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Vicente Flores-Perojo, et al.
Frontiers in Nutrition
|
May 3, 2024
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
Arantza Lamas-Paz, Mariana Mesquita, Marcos Garcia-Lacarte, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 3, 2023
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
Pierluigi Ramadori, Marius Maximilian Woitok, Olga Estévez-Vázquez, et al.
Biomedicines
|
October 23, 2021
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, et al.
Cancers
|
January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Feifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Hepatology Communications
|
June 18, 2021
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Gut Microbes
|
February 21, 2026
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation
Raquel Benedé-Ubieto, Olga Estévez-Vázquez, Rana Acar, et al.
Page
of 2